OtherJun 18, 2026, 01:11 PM
HCW Biologics Inc. Files S-1 Amendment with Updated Exhibit Index
AI Summary
HCW Biologics Inc. filed an S-1 registration statement amendment on June 18, 2026. The filing primarily serves to update the exhibit index, incorporating various agreements and documents by reference or furnishing them. The remainder of the registration statement is unchanged.
Price Impact
More from HCWB
Clinical TrialJun 16, 7:21 AM
HCW Biologics Reports Positive Phase 1 Data for HCW9302 in Alopecia Areata
Clinical TrialJun 16, 7:00 AM
HCW Biologics HCW9302 Phase 1: All 3 patients show positive response
Corporate ActionJun 8, 10:16 AM
HCW Biologics Files S-1 for Resale of 5.7M Shares; Gains Nasdaq Bid Price Exception